Study: Macrolide antibiotics may benefit non-CF bronchiectasis patients

Azithromycin and erythromycin significantly decreased the number of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis, but long-term use increased resistance to the drugs, according to two studies in the Journal of the American Medical Association. Azithromycin and erythromycin enhanced lung function, while azithromycin significantly improved quality of life.

View Full Article in:

PhysiciansBriefing.com · MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD